JP2012135244A - Citrus extract, and method for producing the same - Google Patents
Citrus extract, and method for producing the same Download PDFInfo
- Publication number
- JP2012135244A JP2012135244A JP2010289400A JP2010289400A JP2012135244A JP 2012135244 A JP2012135244 A JP 2012135244A JP 2010289400 A JP2010289400 A JP 2010289400A JP 2010289400 A JP2010289400 A JP 2010289400A JP 2012135244 A JP2012135244 A JP 2012135244A
- Authority
- JP
- Japan
- Prior art keywords
- citrus
- extract
- lower alcohol
- citrus extract
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
Description
本発明は、柑橘原料から得られる柑橘エキスおよびその製造方法に関する。 The present invention relates to a citrus extract obtained from a citrus raw material and a method for producing the citrus extract.
オレンジ、グレープフルーツ、ウンシュウミカン、ナツミカン、レモン、ユズ、ライム、ブンタン、シークワサー、タンカン等のミカン科の柑橘は、果汁を使用した飲料、その他の食品として利用されている。 Citrus citrus fruits such as orange, grapefruit, citrus orange, jujube, lemon, yuzu, lime, buntan, shikwasa, and tankan are used as beverages using fruit juice and other foods.
しかしながら、柑橘は、果実以外の部位や、果汁を搾った後に得られる搾汁残渣等の有効利用はされておらず、ほとんどが廃棄されていた。 However, citrus fruits have not been effectively used for parts other than fruits or juice residue obtained after squeezing fruit juice, and most of them have been discarded.
柑橘の果実以外の部位や搾汁残渣等の利用についてもいくつか報告されている(特許文献1〜8)が、更なる技術を開発する必要があった。
Although some reports have been made on the use of parts other than citrus fruits and juice residues (
本発明は、柑橘の果実以外の部位や搾汁残渣等の利用に関する更なる技術を提供することを課題とした。 This invention made it the subject to provide the further technique regarding utilization of site | parts other than a citrus fruit, squeezed residue, etc.
本発明者らは上記課題を解決するために鋭意研究した結果、柑橘原料を低級アルコールで抽出した後、特殊な合成吸着樹脂で処理することにより、コラゲナーゼ阻害活性やエラスターゼ阻害活性の高いエキスが得られ、これが飲食品や化粧品等に利用できることを見出し、本発明を完成させた。 As a result of diligent research to solve the above-mentioned problems, the present inventors obtained an extract having high collagenase inhibitory activity and elastase inhibitory activity by extracting a citrus raw material with a lower alcohol and then treating with a special synthetic adsorption resin. And found that this can be used for food and drink, cosmetics, etc., and completed the present invention.
すなわち、本発明は次の工程(a)および(b)
(a)柑橘原料を低級アルコールで抽出する工程
(b)工程(a)で得られた低級アルコール抽出物を芳香族系合成吸着樹脂で処理する
工程
を含む工程により得られる柑橘エキスである。
That is, the present invention includes the following steps (a) and (b)
(A) Step of extracting citrus raw material with lower alcohol (b) Citrus extract obtained by a step including a step of treating the lower alcohol extract obtained in step (a) with an aromatic synthetic adsorption resin.
また、本発明は次の工程(a)および(b)
(a)柑橘原料を低級アルコールで抽出する工程
(b)工程(a)で得られた低級アルコール抽出物を芳香族系合成吸着樹脂で処理する
工程
を含むことを特徴とする柑橘エキスの製造方法である。
The present invention also includes the following steps (a) and (b)
(A) a step of extracting a citrus raw material with a lower alcohol (b) a method of producing a citrus extract comprising a step of treating the lower alcohol extract obtained in step (a) with an aromatic synthetic adsorption resin It is.
本発明の柑橘エキスは、柑橘由来の芳香に優れ、各種柑橘由来のポリフェノール、スフィンゴ脂質、植物ステロイド等の機能性物質を多く含む優れたものである。 The citrus extract of the present invention is excellent in fragrance derived from citrus, and is excellent in containing many functional substances such as various citrus-derived polyphenols, sphingolipids, and plant steroids.
本発明の柑橘エキス(以下、「本発明エキス」という)は、次の工程(a)および(b)
(a)柑橘原料を低級アルコールで抽出する工程
(b)工程(a)で得られた低級アルコール抽出物を芳香族系合成吸着樹脂で処理する
工程
を含む工程により得られる。
The citrus extract of the present invention (hereinafter referred to as “the present invention extract”) is prepared by the following steps (a) and (b)
(A) Extracting citrus raw material with lower alcohol (b) Obtained by a process including a process of treating the lower alcohol extract obtained in process (a) with an aromatic synthetic adsorption resin.
本発明エキスの原料となる柑橘原料は、オレンジ(Citrus sinensis (L.) Osbeck)、グレープフルーツ(Citrus Xparadisi)、ウンシュウミカン(citrus unshiu Marc.)、ナツミカン(Citrusnatsudaidai Hayata)、レモン(Citrus limon (L.) Burm.f.)、ユズ(Citrus junos Siebold ex. Taknaka)、ライム(Citrus aurantifolia)、ブンタン(Citrus maxima)、シークワサー(Citrus depressa Hayata)、タンカン(Citrus tankan Hayata)、キンカン(Fortunella)、カラタチ(Poncirus trifoliata)等のミカン科ミカン連の(柑橘)から選ばれる植物の果実、果皮、種子、砂嚢およびその搾汁残渣から選ばれる1種以上である。これらの柑橘原料の中でもシークワサーの搾汁残渣が好ましい。なお、本発明において搾汁残渣とは、果実を公知の搾汁機等で搾汁した後に得られる残渣であり、果皮、種子および砂嚢が含むが、果汁をほとんど含まないものである。また、これら柑橘原料は、公知の手段により乾燥や粉砕をしてあってもよい。 Citrus raw materials used as the raw material of the extract of the present invention are orange (Citrus sinensis (L.) Osbeck), grapefruit (Citrus Xparadisi), citrus unshiu Marc., Jujube (Citrusnatsudaidai Hayata), lemon (Citrus limon (L. ) Burm.f.), Yuzu (Citrus junos Siebold ex. Taknaka), Lime (Citrus aurantifolia), Buntan (Citrus maxima), Sikhwasa (Citrus depressa Hayata), Tankan (Citrus tankan Hayata), Kumquat (Fortunella), Karatachi ( Poncirus trifoliata) is one or more selected from fruits, pericarps, seeds, sandbags and squeezed residues of plants selected from Citrus citrus (citrus). Among these citrus raw materials, squeezer juice residue is preferred. In addition, in this invention, a squeezed residue is a residue obtained after squeezing a fruit with a well-known squeezing machine etc., and contains a fruit skin, a seed, and a sandbag, but hardly contains fruit juice. Moreover, these citrus raw materials may be dried or pulverized by known means.
上記柑橘原料の低級アルコールによる抽出は、特に制限されないが、例えば、低級アルコール中に柑橘原料を、1〜99質量%(以下、単に「%」という)、好ましくは20〜25%浸漬させ、0〜100℃、好ましくは20〜30℃で1分間〜1週間、好ましくは3〜24時間抽出すればよい。この抽出に用いられる低級アルコールとしては、メタノール、エタノール、イソプロピルアルコール、エチレングリコール、グリセリン、1,3−ブチレングリコール等が挙げられる。これらの低級アルコールの中でもエタノールが好ましい。 The extraction of the citrus raw material with a lower alcohol is not particularly limited. For example, the citrus raw material is immersed in 1 to 99% by mass (hereinafter simply referred to as “%”), preferably 20 to 25% in the lower alcohol. Extraction may be performed at -100 ° C, preferably 20-30 ° C for 1 minute to 1 week, preferably 3-24 hours. Examples of the lower alcohol used for this extraction include methanol, ethanol, isopropyl alcohol, ethylene glycol, glycerin, 1,3-butylene glycol and the like. Of these lower alcohols, ethanol is preferred.
上記抽出により得られた低級アルコール抽出物は、後述する芳香族系合成吸着樹脂による処理の前に、遠心分離等の公知の手段で抽出液と抽出残渣に分離しておくことが好ましい。また、抽出液は公知の手段で濃縮しておいてもよい。 The lower alcohol extract obtained by the extraction is preferably separated into an extract and an extraction residue by a known means such as centrifugation before the treatment with the aromatic synthetic adsorption resin described later. The extract may be concentrated by a known means.
上記抽出物は、次いで、芳香族系合成吸着樹脂で処理する。この処理に用いられる芳香族系吸着樹脂としては、例えば、スチレン−ベンゼン系の樹脂が挙げられる。このような樹脂の市販品としては、ダイヤイオン(登録商標)HP−20、HP−21(三菱化学社製)等が挙げられる。 The extract is then treated with an aromatic synthetic adsorption resin. Examples of the aromatic adsorption resin used for this treatment include styrene-benzene resin. Examples of such commercially available resins include Diaion (registered trademark) HP-20, HP-21 (manufactured by Mitsubishi Chemical Corporation), and the like.
上記芳香族系合成吸着樹脂を用いて上記抽出物を処理する方法は、特に制限されないが、例えば、抽出物を芳香族系合成吸着樹脂に接触させて本発明エキスを樹脂に吸着させ、次いで、樹脂に吸着した本発明エキスを溶出させる方法等が挙げられる。具体的に、抽出物中の本発明エキスを芳香族系合成吸着樹脂に吸着させるには、芳香族系合成吸着樹脂を充填したカラムに1〜99%、好ましくは10〜90%、より好ましくは20〜60%エタノール水溶液を十分に通液した後、抽出物を通液させればよい。また、樹脂に吸着させた本発明エキスを溶出させるには、吸着させた時に用いたエタノール水溶液よりもエタノール濃度が高い、2〜100%、好ましくは70〜100%エタノール水溶液をカラムに通液させればよい。 The method of treating the extract with the aromatic synthetic adsorption resin is not particularly limited, but for example, the extract is brought into contact with the aromatic synthetic adsorption resin to adsorb the extract of the present invention to the resin, and then, Examples include a method of eluting the extract of the present invention adsorbed on a resin. Specifically, in order to adsorb the extract of the present invention in the extract onto the aromatic synthetic adsorption resin, it is 1 to 99%, preferably 10 to 90%, more preferably on a column packed with the aromatic synthetic adsorption resin. What is necessary is just to let an extract pass, after fully passing 20-60% ethanol aqueous solution. In order to elute the extract of the present invention adsorbed on the resin, a 2 to 100%, preferably 70 to 100% aqueous ethanol solution having a higher ethanol concentration than the aqueous ethanol solution used at the time of adsorption is passed through the column. Just do it.
また、上記処理をした後は、液液分配、カラムクロマトグラフィー等の公知の精製手段で本発明エキスを精製してもよい。 Further, after the above treatment, the extract of the present invention may be purified by a known purification means such as liquid-liquid distribution or column chromatography.
上記工程(a)および(b)を含む工程により得られる本発明エキスは、柑橘由来の芳香に優れ、各種柑橘由来のポリフェノール、スフィンゴ脂質、植物ステロイド等の機能性物質が多く含まれている。そのため、本発明エキスは、従来の植物由来の抽出物が利用されている、化粧水、化粧クリーム、石けん等の化粧品、飲料、アメ、氷菓等の飲食品、香料等に用いることができる。 The extract of the present invention obtained by the steps including the steps (a) and (b) is excellent in citrus-derived fragrance, and contains a large amount of functional substances such as various citrus-derived polyphenols, sphingolipids, and plant steroids. Therefore, the extract of the present invention can be used for cosmetics such as lotion, cosmetic cream and soap, foods and beverages such as beverages, candy and ice confectionery, fragrances and the like in which conventional plant-derived extracts are used.
なお、本発明エキスは、コラゲナーゼ阻害活性(IC50)が1.0〜120μg/ml、好ましくは1.0〜12.0μg/mlであり、エラスターゼ阻害活性(IC50)が0.5〜50μg/ml、好ましくは0.5〜5.0μg/mlである。そのため、本発明エキスは、特に化粧品に用いることが好ましい。本明細書においてコラゲナーゼ阻害活性およびエラスターゼ阻害活性は、文献記載の方法(薬学雑誌Vol.118、pp423〜429、(1998)および機能性化粧品素材開発のための実験法−in vitro/細胞/組織培養、芋川玄爾著、シーエムシー出版、pp60〜64、(2007))や後述する実施例に記載の方法により測定された値である。 The extract of the present invention has a collagenase inhibitory activity (IC 50 ) of 1.0 to 120 μg / ml, preferably 1.0 to 12.0 μg / ml, and an elastase inhibitory activity (IC 50 ) of 0.5 to 50 μg. / Ml, preferably 0.5 to 5.0 μg / ml. Therefore, the extract of the present invention is particularly preferably used for cosmetics. In the present specification, collagenase inhibitory activity and elastase inhibitory activity are determined according to literature methods (Pharmaceutical Journal Vol. 118, pp 423-429, (1998) and experimental methods for developing functional cosmetic materials-in vitro / cell / tissue culture). It is a value measured by the method as described in Sakagawa Genso, CMC Publishing, pp 60-64, (2007)) and the examples described later.
また、本発明エキスには、次の式(I)または(II)で表される新規なセラミド配糖体が含まれる。なお、これらセラミド配糖体は本発明エキスから図1に記載の方法により得ることができる。
これらセラミド配糖体の物性は以下の通りである。
・ろう状白色粉末
・水、エーテル、石油エーテルに不溶で、ピリジン、クロロホルム、熱エタノールに可溶
・比較的安定で長期間保存可
・セレブロン画分は融点212〜215℃、比旋光度[α]22 D+3.98°
・ケラシン画分は融点185〜187℃、比旋光度[α]22 D−3.82°
・ネルボン画分は融点180℃、比旋光度[α]22 D−3.70°
・オキシネルボン画分は融点205〜210℃、比旋光度[α]22 D+3.80°
・分子量713(質量分析法)
The physical properties of these ceramide glycosides are as follows.
・ Waxy white powder ・ Insoluble in water, ether and petroleum ether, soluble in pyridine, chloroform and hot ethanol ・ Relatively stable and can be stored for a long time ・ Celebron fraction has a melting point of 212 to 215 ° C., specific rotation [α ] 22 D + 3.98 °
-Keracin fraction has a melting point of 185 to 187 ° C, specific rotation [α] 22 D -3.82 °
・ Nelbon fraction has a melting point of 180 ° C. and specific rotation [α] 22 D −3.70 °
・ Oxinerbon fraction has a melting point of 205 to 210 ° C., specific rotation [α] 22 D + 3.80 °
・ Molecular weight 713 (mass spectrometry)
これらセラミド配糖体は、化粧水、化粧クリーム、石けん等の化粧品、ドリンク、ゼリー、サプリメント等の飲食品、塗り薬、軟膏等の医薬品、医薬部外品等に用いることができる。 These ceramide glycosides can be used in cosmetics such as lotions, cosmetic creams, and soaps, foods and drinks such as drinks, jellies, and supplements, pharmaceuticals such as paints and ointments, quasi drugs, and the like.
更に、本発明エキスには、次の式(III)で表される新規なステロイド配糖体が含まれる。なお、このステロイド配糖体は本発明エキスから図1に記載の方法により得ることができる。
このステロイド配糖体の物性は以下の通りである。
・白色粉末
・クロロホルム、ピリジンに易溶、メタノール、エタノールに可溶、水に難溶
・融点は293〜294℃、比旋光度[α]25 D−40.0°(c2.6、ピリジン)
・分子量576(質量分析法)
The physical properties of this steroid glycoside are as follows.
・ White powder ・ Easily soluble in chloroform and pyridine, soluble in methanol and ethanol, hardly soluble in water ・ Melting point: 293-294 ° C., specific rotation [α] 25 D -40.0 ° (c 2.6, pyridine)
・ Molecular weight 576 (mass spectrometry)
このステロイド配糖体は石けん、シャンプー等の化粧品、軟膏、栄養ドリンク、シロップ、うがい薬などの医薬品、医薬部外品等に用いることができる。 This steroid glycoside can be used in cosmetics such as soap and shampoo, ointments, energy drinks, syrups, gargles and other pharmaceutical products, quasi drugs and the like.
以下、本発明を実施例を挙げて詳細に説明するが、本発明はこれら実施例に何ら限定されるものではない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated in detail, this invention is not limited to these Examples at all.
実 施 例 1
柑橘エキスの製造:
シークワサーの搾汁残渣15kgを凍結乾燥機にかけて、凍結乾燥物3kgを得た。この凍結乾燥物3kgを粉砕した後、95%エタノールを12l加え、室温(20℃)で一晩(12時間)抽出した。抽出した凍結乾燥物とエタノールの混合物を、遠心分離機を使って、抽出液と抽出残渣に分離し、抽出液を9L得た。
Example 1
Production of citrus extract:
15 kg of squeezer squeezed residue was put on a freeze dryer to obtain 3 kg of freeze-dried product. After 3 kg of this lyophilized product was pulverized, 12 l of 95% ethanol was added and extracted overnight (12 hours) at room temperature (20 ° C.). The extracted lyophilized product and ethanol mixture was separated into an extract and an extraction residue using a centrifuge, and 9 L of extract was obtained.
あらかじめ95%エタノールに浸しておいた芳香族系合成吸着樹脂(ダイヤイオン(登録商標)HP−20:三菱化学製)の500mLを直径6cmのカラムに詰め、57%エタノールを3L透過した。上記で得た抽出液9Lに蒸留水を6L加水し攪拌した後、上記で準備したカラムに通して、芳香族系合成吸着剤(ダイヤイオンHP−20:三菱化学製)にエキスを吸着させた。その後、57%エタノール2000mLを透過してカラム内の不純物を洗浄した。次いで、83%エタノール2.2Lをカラムに通してエキスを溶離させ、溶離液2.2Lを得た。溶離液2.2Lに対し、1,3−ブチレングリコールを1.0L加えて混合した後、ロータリーエバポレーターでエタノールを取り除き、減圧濃縮し、柑橘エキスを1.0kg得た。 500 mL of an aromatic synthetic adsorption resin (Diaion (registered trademark) HP-20: manufactured by Mitsubishi Chemical) previously immersed in 95% ethanol was packed in a 6 cm diameter column, and 3 L of 57% ethanol was permeated. After 6 L of distilled water was added to 9 L of the extract obtained above and stirred, the extract was adsorbed on an aromatic synthetic adsorbent (Diaion HP-20: manufactured by Mitsubishi Chemical) through the column prepared above. . Thereafter, 2000 mL of 57% ethanol was permeated to wash impurities in the column. Subsequently, the extract was eluted by passing 2.2 L of 83% ethanol through the column to obtain 2.2 L of an eluent. After adding 1.0 L of 1,3-butylene glycol to 2.2 L of the eluent and mixing, ethanol was removed by a rotary evaporator and concentrated under reduced pressure to obtain 1.0 kg of citrus extract.
実 施 例 2
柑橘エキスのコラゲナーゼ阻害活性の測定:
(1)コラゲナーゼ阻害活性試薬の調整
トリスアミノメタン(和光純薬工業製)および塩酸を0.1Mに調整し、塩化カリウム(和光純薬工業製)を20mM含んだ0.1Mトリス塩酸緩衝液(pH7.1)を作製した。Pz−ペプチド(Pz−Pro−Leu−Gly−Pro−D−Arg−OH:フコナシ製)を7.8mg量りとり、0.1Mトリス塩酸緩衝液20mLに溶解したものを基質溶液とした。また、コラーゲナーゼ タイプIV(Clostridium hystolyticum由来:シグマ製)5mgを蒸留水1mlに溶解させた液を、酵素溶液とした。これを100μlずつ分注、−20℃で保管し、使用時に蒸留水で50倍に希釈して反応に用いた。更に、クエン酸(和光純薬工業製)を25mMに調整したものを反応停止液とした。
Example 2
Determination of collagenase inhibitory activity of citrus extract:
(1) Preparation of Collagenase Inhibiting Activity Reagent Trisaminomethane (manufactured by Wako Pure Chemical Industries) and hydrochloric acid were adjusted to 0.1M, and 0.1M Tris-HCl buffer (containing 20 mM potassium chloride (manufactured by Wako Pure Chemical Industries)) ( pH 7.1) was prepared. 7.8 mg of Pz-peptide (Pz-Pro-Leu-Gly-Pro-D-Arg-OH: manufactured by Fukonashi) was weighed and dissolved in 20 mL of 0.1 M Tris-HCl buffer solution as a substrate solution. Further, a solution obtained by dissolving 5 mg of collagenase type IV (from Clostridium hystolyticum: Sigma) in 1 ml of distilled water was used as an enzyme solution. This was dispensed in 100 μl aliquots, stored at −20 ° C., and diluted 50 times with distilled water at the time of use. Furthermore, what adjusted citric acid (made by Wako Pure Chemical Industries) to 25 mM was used as the reaction stop liquid.
(2)コラゲナーゼ阻害活性の測定方法
実施例1で製造した柑橘エキス5mLを、固形分が55.1mgとなるまで濃縮した。これを50%ジメチルスルホキシド2.5mLに溶解し、更に蒸留水で400倍希釈して固形分55μg/mLの試料溶液を調製した。試料溶液25μLと酵素溶液25μL、基質溶液200μLを混合し、固形分を5.5μg/mLに調整した後、37℃で30分間インキュベーションした。インキュベーション後、反応停止液0.5mlで反応を停止し、更に、酢酸エチル2.5mlを加え、抽出した。次にこれを3000rpm、10分間遠心分離し、酢酸エチルを対照として、酢酸エチル層の波長320nmにおける吸光度を測定した。試料溶液のブランクには、試料溶液に蒸留水と基質溶液を加えた液、コントロールには蒸留水に酵素溶液と基質溶液を加えた液、コントロールのブランクには蒸留水に基質溶液を加えた液を使用して酵素反応後に酢酸エチル層の波長320nmの吸光度を測定した。
(2) Method for measuring collagenase inhibitory activity 5 mL of the citrus extract produced in Example 1 was concentrated until the solid content was 55.1 mg. This was dissolved in 2.5 mL of 50% dimethyl sulfoxide, and further diluted 400 times with distilled water to prepare a sample solution having a solid content of 55 μg / mL. 25 μL of the sample solution, 25 μL of the enzyme solution, and 200 μL of the substrate solution were mixed to adjust the solid content to 5.5 μg / mL, and then incubated at 37 ° C. for 30 minutes. After the incubation, the reaction was stopped with 0.5 ml of a reaction stop solution, and further 2.5 ml of ethyl acetate was added for extraction. Next, this was centrifuged at 3000 rpm for 10 minutes, and the absorbance at a wavelength of 320 nm of the ethyl acetate layer was measured using ethyl acetate as a control. The sample solution blank contains a sample solution containing distilled water and a substrate solution, the control solution contains distilled water and an enzyme solution and a substrate solution, and the control blank contains a substrate solution added to the distilled water. After the enzyme reaction, the absorbance of the ethyl acetate layer at a wavelength of 320 nm was measured.
吸光度の値からコラゲナーゼ阻害率を次式により算出した。
柑橘エキスの固形分5.5μg/mLに対しコラゲナーゼの阻害率は51.6%だった。このコラゲナーゼの阻害率をIC50に換算した結果と、その他公知のコラゲナーゼ阻害活性の値を併せて表1に示した。 The inhibition rate of collagenase was 51.6% with respect to the solid content of the citrus extract of 5.5 μg / mL. The results of converting the inhibition rate of this collagenase into IC 50 and the values of other known collagenase inhibitory activities are shown in Table 1.
実 施 例 3
柑橘エキスのエラスターゼ阻害活性の測定:
(1)エラスターゼ阻害活性の試薬の調整
トリスアミノメタン(和光純薬工業製)および塩酸を0.2Mに調整し、0.2Mのトリス塩酸緩衝液(pH8.0)を作製した。N−スクシニル−L−アラニル−L−アラニル−L−アラニン−p−ニトロアニリドを4.52mg量りとり、ジメチルスルホキシド200μLに溶解し、使用時に0.2Mトリス塩酸緩衝液で10倍希釈した液を基質溶液とした。また、ヒトエラスターゼ(フコナシ製)を蒸留水で希釈して10μg/mLとした液を酵素溶液とした。
Example 3
Measurement of elastase inhibitory activity of citrus extract:
(1) Preparation of elastase inhibitory activity reagent Trisaminomethane (manufactured by Wako Pure Chemical Industries, Ltd.) and hydrochloric acid were adjusted to 0.2M to prepare 0.2M Tris-HCl buffer (pH 8.0). N-succinyl-L-alanyl-L-alanyl-L-alanine-p-nitroanilide weighed 4.52 mg, dissolved in 200 μL of dimethyl sulfoxide, and diluted 10-fold with 0.2 M Tris-HCl buffer at the time of use. A substrate solution was obtained. Further, human elastase (manufactured by Fukonashi) was diluted with distilled water to make 10 μg / mL as an enzyme solution.
(2)エラスターゼ阻害活性の測定方法
実施例1で製造した柑橘エキス5mLを、固形分が55.1mgとなるまで濃縮した。これを50%ジメチルスルホキシド2.5mLに溶解し、更に蒸留水で4000倍希釈して固形分5.5μg/mLの試料溶液を調製した。マイクロプレート上に試料溶液50μLと酵素溶液100μL、基質溶液50μLを混合し、固形分1.4μg/mLに調整した後、37℃で1時間インキュベーションした。インキュベーション後、すぐにマイクロプレートリーダーを用いて、試料溶液の分解生成物であるp−ニトロアニリドの吸光度(波長405nm)を測定した。試料溶液のブランクには、試料溶液に蒸留水と基質溶液を加えた液、コントロールには蒸留水に酵素溶液と基質溶液を加えた液、コントロールのブランクには蒸留水に基質溶液を加えた液を使用して酵素反応後にp−ニトロアニリドの吸光度(波長405nm)を測定した。
(2) Method for Measuring Elastase Inhibitory Activity 5 mL of the citrus extract produced in Example 1 was concentrated until the solid content was 55.1 mg. This was dissolved in 2.5 mL of 50% dimethyl sulfoxide, and further diluted 4000 times with distilled water to prepare a sample solution having a solid content of 5.5 μg / mL. A sample solution (50 μL), an enzyme solution (100 μL), and a substrate solution (50 μL) were mixed on a microplate, adjusted to a solid content of 1.4 μg / mL, and then incubated at 37 ° C. for 1 hour. Immediately after the incubation, the absorbance (wavelength 405 nm) of p-nitroanilide, which is a degradation product of the sample solution, was measured using a microplate reader. The sample solution blank contains a sample solution containing distilled water and a substrate solution, the control solution contains distilled water and an enzyme solution and a substrate solution, and the control blank contains a substrate solution added to the distilled water. Was used to measure the absorbance (wavelength 405 nm) of p-nitroanilide after the enzyme reaction.
吸光度の値からエラスターゼ阻害率を次式により算出した。
柑橘エキスの固形分1.4μg/mLに対しエラスターゼの阻害率は41.0%だった。このエラスターゼの阻害率をIC50に換算した結果と、その他公知のエラスターゼ阻害活性の値を併せて表2に示した。 The inhibition rate of elastase was 41.0% with respect to the solid content of the citrus extract of 1.4 μg / mL. Table 2 shows the results obtained by converting the inhibition rate of this elastase into IC 50 and the values of other known elastase inhibitory activities.
実 施 例 4
化粧水:
以下の処方の化粧水を以下の製造方法により製造した。
(成分名) (配合量)
(1)柑橘エキス 0.5%
(2)グリセリン 5%
(3)1,3−ブチレングリコール 4%
(4)PEG−11メチルエーテルジメチコン 1%
(5)EDTA−2Na 微量
(6)グリチルリチン酸2K 微量
(7)フェノキシエタノール 1%
(8)メチルパラベン 1%
(9)精製水 残量
Example 4
Lotion:
A lotion having the following formulation was produced by the following production method.
(Ingredient name) (Blending amount)
(1) Citrus extract 0.5%
(2) Glycerin 5%
(3) 1,3-butylene glycol 4%
(4) PEG-11
(5) EDTA-2Na Trace (6) Glycyrrhizic acid 2K Trace (7)
(8)
(9) Purified water remaining
<製造方法>
A:(9)に(2)、(3)、(5)を溶解させた。
B:Aに(1)、(4)、(6)〜(8)を混合したものを添加し、可溶化させ、化粧
水を製造した。
<Manufacturing method>
A: (2), (3) and (5) were dissolved in (9).
B: A mixture of (1), (4), (6) to (8) was added to A and solubilized to produce a lotion.
実 施 例 5
化粧クリーム(1):
以下の処方の化粧クリームを以下の製造方法により製造した。
(成分名) (配合量)
(1)トリ(カプリル/カプリン酸)グリセリル 7%
(2)ホホバオイル 5%
(3)柑橘エキス 3%
(4)ジプロピレングリコール 2%
(5)ベヘニルアルコール 2.25%
(6)ポリビニルアルコール 3%
(7)ペンタステアリン酸デカグリセリル 0.95%
(8)ビーズワックス 0.80%
(9)ステアリン酸スクロース 1%
(10)ステアロイル乳酸ナトリウム 0.80%
(11)ラウレス−7 0.15%
(12)フェノキシエタノール 1%
(13)メチルパラベン 1%
(14)精製水 残量
Example 5
Cosmetic cream (1):
A cosmetic cream having the following formulation was produced by the following production method.
(Ingredient name) (Blending amount)
(1) Tri (capryl / capric acid) glyceryl 7%
(2) Jojoba oil 5%
(3)
(4)
(5) 2.25% behenyl alcohol
(6)
(7) Decaglyceryl pentastearate 0.95%
(8) 0.80% bead wax
(9)
(10) Sodium stearoyl lactate 0.80%
(11) Laureth-7 0.15%
(12)
(13)
(14) Purified water remaining
<製造方法>
A:(14)に(3)と(4)を加え、70℃に加熱した。
B:(1)、(2)、(5)〜(13)を加え、70℃で加熱した。
C:AとBをホモミキサーで乳化粒子が均一となるまで撹拌し、脱気、濾過、冷却をし
、化粧クリームを得た。
<Manufacturing method>
A: (3) and (4) were added to (14) and heated to 70 ° C.
B: (1), (2), (5) to (13) were added and heated at 70 ° C.
C: A and B were stirred with a homomixer until the emulsified particles were uniform, deaerated, filtered and cooled to obtain a cosmetic cream.
実 施 例 6
化粧クリーム(2):
以下の処方の化粧クリームを以下の製造方法により製造した。
(成分名) (配合量)
(1)トリ(カプリル/カプリン酸)グリセリル 12%
(2)ホホバオイル 4%
(3)ジプロピレングリコール 4%
(4)柑橘エキス 3%
(5)PEG−2 水添ヒマシ油 3%
(6)セタノール 1.5%
(7)ポリビニルアルコール 2%
(8)ペンタステアリン酸デカグリセリル 1.33%
(9)ビーズワックス 1.20%
(10)ステアリン酸スクロース 1%
(11)ステアロイル乳酸ナトリウム 0.42%
(12)クインスシードガム 0.3%
(13)アルギニン 0.20%
(14)フェノキシエタノール 1%
(15)メチルパラベン 1%
(16)精製水 残量
Example 6
Cosmetic cream (2):
A cosmetic cream having the following formulation was produced by the following production method.
(Ingredient name) (Blending amount)
(1) Tri (capryl / capric acid) glyceryl 12%
(2) Jojoba oil 4%
(3) Dipropylene glycol 4%
(4)
(5) PEG-2
(6) Cetanol 1.5%
(7)
(8) Decaglyceryl pentastearate 1.33%
(9) Bead wax 1.20%
(10) 1% sucrose stearate
(11) Sodium stearoyl lactate 0.42%
(12) Quinsed gum 0.3%
(13) Arginine 0.20%
(14)
(15)
(16) Remaining amount of purified water
<製造方法>
A:(16)に(3)、(4)を加え、70℃に加熱した。
B:(1)、(2)、(5)〜(15)を加え、70℃に加熱した。
C:AとBをホモミキサーで乳化粒子が均一となるまで撹拌し、脱気、濾過、冷却をし
、化粧クリームを得た。
<Manufacturing method>
A: (3) and (4) were added to (16) and heated to 70 ° C.
B: (1), (2), (5) to (15) were added and heated to 70 ° C.
C: A and B were stirred with a homomixer until the emulsified particles were uniform, deaerated, filtered and cooled to obtain a cosmetic cream.
実 施 例 7
石けん(1):
以下の処方の石けんを以下の製造方法により製造した。
(成分名) (配合量)
(1)パーム油 22.0%
(2)パーム核油 10.0%
(3)ヒマシ油 4.0%
(4)オリーブ油 4.0%
(5)苛性ソーダ 6.0%
(6)エチルアルコール 20.0%
(7)精製水 20.0%
(8)砂糖 9.0%
(9)グリセリン 4.5%
(10)柑橘エキス 0.5%
Example 7
Soap (1):
Soap having the following formulation was manufactured by the following manufacturing method.
(Ingredient name) (Blending amount)
(1) Palm oil 22.0%
(2) Palm kernel oil 10.0%
(3) Castor oil 4.0%
(4) 4.0% olive oil
(5) Caustic soda 6.0%
(6) Ethyl alcohol 20.0%
(7) Purified water 20.0%
(8) Sugar 9.0%
(9) Glycerin 4.5%
(10) Citrus extract 0.5%
<製造方法>
A:(1)〜(7)を湯浴上で加熱しながらケン化した。
B:Aに(8)〜(10)を加えて混合し、篩で濾過して型入れした。
C:Bを冷蔵庫で固化させた後、40日間乾燥熟成させて石けんを得た。
<Manufacturing method>
A: Saponification was performed while heating (1) to (7) on a hot water bath.
B: (8) to (10) were added to A, mixed, filtered through a sieve and put into a mold.
C: B was solidified in a refrigerator and then dried and aged for 40 days to obtain soap.
実 施 例 8
石けん(2):
以下の処方の石けんを以下の製造方法により製造した。
(成分名) (配合量)
(1)パーム油 22.0%
(2)パーム核油 10.0%
(3)ヒマシ油 7.0%
(4)オリーブ油 22.0%
(5)苛性ソーダ 6.0%
(6)苛性カリ 3.5%
(7)ホホバ種子油 3.0%
(8)加水分解コラーゲン 2.0%
(9)二酸化チタン 1.0%
(10)柑橘エキス 0.5%
(11)精製水 23.0%
Example 8
Soap (2):
Soap having the following formulation was manufactured by the following manufacturing method.
(Ingredient name) (Blending amount)
(1) Palm oil 22.0%
(2) Palm kernel oil 10.0%
(3) Castor oil 7.0%
(4) 22.0% olive oil
(5) Caustic soda 6.0%
(6) Caustic potash 3.5%
(7) Jojoba seed oil 3.0%
(8) Hydrolyzed collagen 2.0%
(9) Titanium dioxide 1.0%
(10) Citrus extract 0.5%
(11) Purified water 23.0%
<製造方法>
A:(1)〜(6)、(11)を湯浴上で加熱しながらケン化した。
B:Aに(7)〜(10)を加えて混合し、篩で濾過して型入れした。
C:Bを冷蔵庫で固化させた後、40日間乾燥熟成させて石けんを得た。
<Manufacturing method>
A: Saponification was performed while heating (1) to (6) and (11) on a hot water bath.
B: (7) to (10) were added to A, mixed, filtered through a sieve and put into a mold.
C: B was solidified in a refrigerator and then dried and aged for 40 days to obtain soap.
実 施 例 9
セラミド配糖体およびステロイド配糖体の精製:
実施例1で得られた柑橘エキスを用い、図1に記載の方法に従って、セラミド配糖体(SQC1およびSQC2)とステロイド配糖体(SQSG1)を精製した。ステロイド配糖体とセラミド配糖体の構造を質量分析法とプロトン核磁気共鳴分光法にて分析した結果、以下の構造式を有することがわかった。
Example 9
Purification of ceramide glycosides and steroid glycosides:
Using the citrus extract obtained in Example 1, ceramide glycosides (SQC1 and SQC2) and steroid glycoside (SQSG1) were purified according to the method described in FIG. As a result of analyzing the structure of steroid glycoside and ceramide glycoside by mass spectrometry and proton nuclear magnetic resonance spectroscopy, it was found to have the following structural formula.
セラミド配糖体(SQC1)
ステロイド配糖体(SQSG1)
本発明の柑橘エキスは、柑橘由来の芳香に優れ、各種柑橘由来の機能性物質が多く含まれている。そのため、本発明の柑橘エキスは、化粧水、化粧クリーム、石けん等の化粧品、飲料、アメ、氷菓等の飲食品、香料等に用いることができる。
The citrus extract of the present invention is excellent in citrus-derived fragrance and contains many functional substances derived from various citrus fruits. Therefore, the citrus extract of the present invention can be used for cosmetics such as skin lotion, cosmetic cream, soap, and the like, beverages, candy and other foods such as ice confectionery, and fragrances.
Claims (9)
(a)柑橘原料を低級アルコールで抽出する工程
(b)工程(a)で得られた低級アルコール抽出物を芳香族系合成吸着樹脂で処理する
工程
を含む工程により得られる柑橘エキス。 Next steps (a) and (b)
(A) The process of extracting a citrus raw material with a lower alcohol (b) The citrus extract obtained by the process including the process of processing the lower alcohol extract obtained at the process (a) with an aromatic synthetic adsorption resin.
(a)柑橘原料を低級アルコールで抽出する工程
(b)工程(a)で得られた低級アルコール抽出物を芳香族系合成吸着樹脂で処理する
工程
を含むことを特徴とする柑橘エキスの製造方法。 Next steps (a) and (b)
(A) a step of extracting a citrus raw material with a lower alcohol (b) a method of producing a citrus extract comprising a step of treating the lower alcohol extract obtained in step (a) with an aromatic synthetic adsorption resin .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010289400A JP2012135244A (en) | 2010-12-27 | 2010-12-27 | Citrus extract, and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010289400A JP2012135244A (en) | 2010-12-27 | 2010-12-27 | Citrus extract, and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2012135244A true JP2012135244A (en) | 2012-07-19 |
Family
ID=46673257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010289400A Pending JP2012135244A (en) | 2010-12-27 | 2010-12-27 | Citrus extract, and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2012135244A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020076103A1 (en) * | 2018-10-11 | 2020-04-16 | (주)아모레퍼시픽 | Composition for inhibiting cortisone reductase |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003221592A (en) * | 2002-02-01 | 2003-08-08 | Unitika Ltd | Method for purifying sphingoglycolipid |
JP2003342123A (en) * | 2002-05-31 | 2003-12-03 | Ichimaru Pharcos Co Ltd | Collagenase activity inhibitor, elastase activity inhibitor and cosmetic composition |
JP2004083416A (en) * | 2002-08-22 | 2004-03-18 | Takeda Food Products Ltd | Skin care preparation for external use and food and drink product |
JP2007112852A (en) * | 2005-10-18 | 2007-05-10 | Pokka Corp | Method for producing polyphenol-containing material, and food and drink |
JP2009155298A (en) * | 2007-12-27 | 2009-07-16 | Pokka Corp | Eriocitrin-containing substance, production method thereof, and food and drink, pharmaceutical and cosmetic compounded with eriocitrin-containing substance |
WO2010026946A1 (en) * | 2008-09-02 | 2010-03-11 | 高砂香料工業株式会社 | Flavor improving agent |
-
2010
- 2010-12-27 JP JP2010289400A patent/JP2012135244A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003221592A (en) * | 2002-02-01 | 2003-08-08 | Unitika Ltd | Method for purifying sphingoglycolipid |
JP2003342123A (en) * | 2002-05-31 | 2003-12-03 | Ichimaru Pharcos Co Ltd | Collagenase activity inhibitor, elastase activity inhibitor and cosmetic composition |
JP2004083416A (en) * | 2002-08-22 | 2004-03-18 | Takeda Food Products Ltd | Skin care preparation for external use and food and drink product |
JP2007112852A (en) * | 2005-10-18 | 2007-05-10 | Pokka Corp | Method for producing polyphenol-containing material, and food and drink |
JP2009155298A (en) * | 2007-12-27 | 2009-07-16 | Pokka Corp | Eriocitrin-containing substance, production method thereof, and food and drink, pharmaceutical and cosmetic compounded with eriocitrin-containing substance |
WO2010026946A1 (en) * | 2008-09-02 | 2010-03-11 | 高砂香料工業株式会社 | Flavor improving agent |
Non-Patent Citations (1)
Title |
---|
日本薬学会第130年会要旨集2, JPN6015000242, 5 March 2010 (2010-03-05), pages 225 - 29, ISSN: 0002978973 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020076103A1 (en) * | 2018-10-11 | 2020-04-16 | (주)아모레퍼시픽 | Composition for inhibiting cortisone reductase |
CN112804985A (en) * | 2018-10-11 | 2021-05-14 | 株式会社爱茉莉太平洋 | Composition for inhibiting cortisone reductase |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | Parameters affecting the extraction of ginsenosides from the adventitious roots of ginseng (Panax ginseng CA Meyer) | |
Han et al. | Free radical scavenging effect of Diospyros kaki, Laminaria japonica and Undaria pinnatifida | |
KR101588613B1 (en) | Method for producing citrus fruits extract with high nobiletin or tangeretin content and use thereof | |
Lin et al. | Production of nigragillin and dihydrophaseic acid by biotransformation of litchi pericarp with Aspergillus awamori and their antioxidant activities | |
Raspe et al. | Compounds from Stevia rebaudiana Bertoni leaves: An overview of non-conventional extraction methods and challenges | |
KR20150060407A (en) | Method for preparing Red Ginseng extracts containing abundant ginsenosid Rg3 | |
JP2007045755A (en) | Bleaching agent, antiallergic agent and food | |
JP2011042627A (en) | Hyaluronic acid synthesis promoter | |
JP5306605B2 (en) | Topical skin preparation | |
JP2008297214A (en) | Composition having skin-beautifying effect | |
JP2012135244A (en) | Citrus extract, and method for producing the same | |
JP2021533091A (en) | Antioxidant composition containing novel ginsenosides | |
JP6120531B2 (en) | Method for producing hydrothermally-treated extract derived from sesame | |
CN102217755B (en) | Production method of Kusamaki seed extract and product | |
JP2016088857A (en) | Nervonic acid derivative exhibiting amyloid formation inhibitory action and method for producing the derivative | |
KR101605122B1 (en) | Method for producing citrus fruits extract with high nobiletin or tangeretin content and use thereof | |
TW201036648A (en) | Composition containing piceatannol and method for preparing same | |
JP5312749B2 (en) | Skin preparations and food | |
Xue et al. | Research progress in extraction, purification, structure of fruit and vegetable polysaccharides and their interaction with anthocyanins/starch | |
KR101661423B1 (en) | anti-oxidant and anti-inflammation composition extracted from Isodon excisus, and its extracting method | |
JP2005179291A (en) | Beta-endorphin production promoting agent | |
Kushwaha et al. | The phytochemical profiling of Aloe vera through GC-MS and compounds activity validation at NCBI for industrial value addition of the plant. | |
JP5951077B2 (en) | Hyaluronic acid synthesis accelerator | |
JP5399467B2 (en) | Composition exhibiting skin epithelial cell proliferation promoting action | |
WO2022254867A1 (en) | Novel phenylpropanoid compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131213 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141219 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150113 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150310 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150818 |